Masimo (NASDAQ:MASI) Reaches New 1-Year Low – Time to Sell?

Shares of Masimo Corporation (NASDAQ:MASI) hit a new 52-week low during trading on Monday . The stock traded as low as $126.57 and last traded at $128.1660, with a volume of 601418 shares trading hands. The stock had previously closed at $130.06.

Analysts Set New Price Targets

MASI has been the subject of several recent analyst reports. Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Zacks Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. BTIG Research boosted their price objective on shares of Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Wells Fargo & Company reiterated an “overweight” rating and set a $190.00 target price on shares of Masimo in a research note on Friday, December 5th. Finally, Bank of America assumed coverage on Masimo in a report on Monday, November 17th. They issued a “neutral” rating and a $162.00 target price for the company. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $189.40.

Masimo Price Performance

The stock has a market capitalization of $6.95 billion, a PE ratio of -12.28, a PEG ratio of 1.30 and a beta of 1.26. The firm’s fifty day moving average price is $140.77 and its two-hundred day moving average price is $148.13. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69.

Masimo (NASDAQ:MASI) last posted its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 EPS for the quarter. The business had revenue of $617.00 million during the quarter. Masimo had a negative net margin of 33.20% and a positive return on equity of 33.04%. On average, equities analysts predict that Masimo Corporation will post 4.1 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Nordea Investment Management AB raised its stake in Masimo by 21.6% during the 2nd quarter. Nordea Investment Management AB now owns 31,868 shares of the medical equipment provider’s stock valued at $5,330,000 after purchasing an additional 5,659 shares during the period. 4D Advisors LLC grew its holdings in Masimo by 50.0% during the 2nd quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after buying an additional 15,000 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock valued at $198,702,000 after buying an additional 509,724 shares in the last quarter. Strs Ohio bought a new stake in shares of Masimo during the first quarter valued at approximately $6,686,000. Finally, Swedbank AB purchased a new position in shares of Masimo in the first quarter worth $12,645,000. Institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.